| Trial ID: | L0807 |
| Source ID: | NCT01247090
|
| Associated Drug: |
Vasopressin - Very Low Dose
|
| Title: |
Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01247090/results
|
| Conditions: |
Hypertension|End Stage Renal Disease
|
| Interventions: |
DRUG: Vasopressin - Very Low Dose|DRUG: Vasopressin - Low Dose|DRUG: Placebo Comparator
|
| Outcome Measures: |
Primary: Change in Mean Interdialytic 44-hour Ambulatory Systolic Blood Pressure Over a 2 Week Follow-up Period, This is designed to measure if the administration of intradialytic AVP will result in change in systolic blood pressure., Baseline and Two Weeks |
|
| Sponsor/Collaborators: |
Sponsor: Columbia University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-10
|
| Completion Date: |
2018-08
|
| Results First Posted: |
2011-04-28
|
| Last Update Posted: |
2019-11-18
|
| Locations: |
Columbia University Medical Center, New York, New York, 10032, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01247090
|
